DischargeBench: Pre-Deployment Evaluation of LLM Discharge Educators through Persona-Grounded Patient Simulation
Organizations: University of Massachusetts Lowell
Abstract
Effective discharge education is personalized: a clinician adapts the discharge plan to each patient's literacy, recall, and personality. Before large language models (LLMs) take on this role with real patients, they need to be evaluated in conversations with diverse patients, yet existing evaluations target static, artifact-generation, or question-answering tasks. We introduce DischargeBench, a pre-deployment benchmark in which a candidate LLM educator teaches a persona-grounded simulated patient in an open-ended, multi-turn conversation. We curate MIMIC-IV-Ext-DischargeBench, 320 cases across 16 ICD chapters, each paired with a patient persona that varies personality, education level, health literacy, and recall. Each conversation is scored on Conversation Quality, Topic Checklist Score (TCS), Simulated Comprehension Score (SCS), and a Claim-Level Safety Audit (CLSA) by an LLM judge validated against physician annotations. Across eight closed- and open-source LLMs, the best model scored only 0.70 on TCS and 0.72 on SCS, and distrustful and anxious patients lowered comprehension for every model. DischargeBench is intended as a screening step before human evaluation, not as evidence of readiness to educate patients.
Figures & tables
| Component | Values |
|---|---|
| From MIMIC-IV (per case) | |
| Demographics | Age, gender, race/ethnicity |
| ICD chapter | 16 merged chapters, 20 cases each |
| Clinical profile | Diagnoses, medications, allergies, medical and family history, reason for admission |
| Assigned persona traits | |
| Personality | Neutral, high-conscientiousness, minimizer, anxious, distrustful |
| Evaluation | Metric | P–P | Judge–P |
|---|---|---|---|
| Conversation Quality a | Spearman | 0.213 | 0.276 |
| AC2 (quad) | 0.868 | 0.820 | |
| TCS c | Cohen’s | 0.686 | 0.600 |
| SCS c | w (quad) | 0.815 | 0.622 |
| CLSA grounding b | Cohen’s | 0.669 | 0.574 |
| CLSA clinical status b | w (quad) | 0.589 | 0.412 |
Appendix figures & tables15 assets
Supplementary material from the paper’s appendix.
Appendix
| Missing | Overall | ||
| n | 320 | ||
| Gender, n (%) | female | 170 (53.1) | |
| male | 150 (46.9) | ||
| Age, mean (SD) | 0 | 47.5 (11.8) | |
| Race, n (%) | WHITE | 178 (55.6) | |
| BLACK/AFRICAN AMERICAN | 59 (18.4) |
| Clinical status | |||
| Grounding | Appropriate | Questionable | Harmful |
| Entailed | Faithful relay | Vague relay | Relayed harm |
| Contradicted | Drift | Drift | Wrong instruction |
| Neutral | Ungrounded- plausible | Unsupported vague | Unsafe advice |
| Topic | Weight | Question |
|---|---|---|
| Discharge diagnosis | 1 | Q1. Did the conversation discuss the patient’s main discharge diagnosis (or chief complaint) mentioned in the patient note? |
| New medication | 1 | Q2. Did the conversation discuss newly added discharge medications mentioned in the patient note? |
| New medication | 0.5 | Q2.1. Did the conversation discuss the exact dosage of the medication mentioned in the patient note? |
| New medication | 0.5 | Q2.2. Did the conversation discuss the exact route of the medication mentioned in the patient note (e.g., oral, injection, intravenous)? |
| New medication | 0.5 | Q2.3. Did the conversation discuss the frequency of medication administration mentioned in the patient note (e.g., twice daily, once at bedtime)? |
| New medication | 0.5 | Q2.4. Did the conversation discuss any side effects or precautions related to the medication mentioned in the patient note? |
| SCS question | Clinical area (matching TCS topic) |
|---|---|
| 1. What was the discharge diagnosis? | Discharge diagnosis (TCS Q1) |
| 2. What treatments did the patient receive from the hospital? | Treatment during stay (TCS Q3) |
| 3. What were the post-discharge treatments recommended to the patient? | Post-discharge treatment (TCS Q4) |
| 4. What doctors or clinics does the patient have to follow up with after this visit? | Follow-up appointment (TCS Q6) |
| 5. For what symptoms or changes should the patient return to the ED/hospital? | Return to hospital (TCS Q5) |
| 6. List the medications that the patient should take, with their name, dosage, and route. | Medications (TCS Q2, which covers new medications only) |
| Spearman | Gwet’s AC2 (quadratic) | |||
|---|---|---|---|---|
| Axis | P–P | Judge–P | P–P | Judge–P |
| Naturalness | 0.43 [ 0.07, 0.77] | 0.33 [0.04, 0.58] | 0.79 [0.60, 0.93] | 0.65 [0.46, 0.81] |
| Responsiveness | 0.50 [0.18, 0.77] | 0.21 [ 0.06, 0.46] | 0.91 [0.83, 0.97] | 0.91 [0.84, 0.95] |
| Clarity | 0.05 [ 0.37, 0.31] | 0.30 [ 0.01, 0.57] | 0.87 [0.72, 0.96] | 0.89 [0.81, 0.94] |
| Clinical Relevance | 0.03 [ 0.50, 0.58] | 0.26 [ 0.04, 0.51] | 0.90 [0.81, 0.96] | 0.83 [0.73, 0.91] |
| Mean | 0.21 [ 0.09, 0.49] | 0.28 [0.07, 0.46] | 0.87 | 0.82 |
| Abbreviation | ICD Chapter |
|---|---|
| BLD | Diseases of the Blood and Blood-Forming Organs |
| CIR | Diseases of the Circulatory System |
| CON | Congenital Anomalies |
| DIG | Diseases of the Digestive System |
| END | Endocrine, Nutritional and Metabolic Diseases |
| FHS | Factors Influencing Health Status and Contact with Health Services |
| Model | Complete | Short n (%) | Char-break n (%) | Low-TCS short n (%) | Retained |
|---|---|---|---|---|---|
| Llama-3.3-70B-Instruct | 1,505 | 194 (12.9) | 55 (3.7) | 98 (6.5) | 1,353 |
| Qwen3-4B | 1,453 | 357 (24.6) | 14 (1.0) | 47 (3.2) | 1,392 |
| Qwen3-32B | 1,470 | 375 (25.5) | 22 (1.5) | 68 (4.6) | 1,380 |
| MedGemma-4b-it | 1,384 | 236 (17.1) | 24 (1.7) | 84 (6.1) | 1,276 |
| MedGemma-27b-text-it | 1,531 | 144 (9.4) | 48 (3.1) | 62 (4.0) | 1,421 |
| GPT-5.4-nano | 1,519 | 150 (9.9) | 64 (4.2) | 54 (3.6) | 1,401 |
Clinical Language Model Evaluation
Clinical language model evaluation measures whether AI systems are accurate, safe, fair, and useful across medical tasks and care settings.
See all 415 papers